GSK PLC-SPON ADR (GSK) Stock News

NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR - Currency: USD

36.31 -0.16 (-0.44%)

After market: 36.3992 +0.09 (+0.25%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

GSK Latest News, Press Relases and Analysis

All

Press Releases

15 hours ago - By: Yahoo Finance - Mentions: VZ GOOG

Warren Buffett says this book changed his life forever. Here's the real key to long-term gains

a day ago - By: Yahoo Finance

BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510

2 days ago - By: Benzinga

GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning

18 days ago - By: Benzinga - Mentions: PFE

Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons

3 days ago - By: GSK plc

US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation

a month ago - By: Zacks Investment Research

Here's Why GSK (GSK) is a Strong Value Stock

2 months ago - By: Zacks Investment Research - Mentions: AZN

Glaxo (GSK) Up 3.2% Since Last Earnings Report: Can It Continue?

10 days ago - By: GSK plc

GSK begins shipping influenza vaccine doses for the 2025-26 flu season

22 days ago - By: Yahoo Finance

GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment

23 days ago - By: Investor's Business Daily - Mentions: GILD

Why This Looming Supreme Court Decision Could Rattle Gilead Sciences

26 days ago - By: GSK plc

FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis

a month ago - By: Investor's Business Daily - Mentions: KALV

How KalVista Pharma Is Taking On A Rare But Deadly Disease

a month ago - By: Zacks Investment Research - Mentions: GILD NVS

FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention

a month ago - By: GSK plc

GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US

a month ago - By: Investor's Business Daily - Mentions: PFE MRNA BNTX NVAX ...

Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.

a month ago - By: Zacks Investment Research - Mentions: MYGN

Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?

2 months ago - By: Theravance Biopharma, Inc. - Mentions: TBPH

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

2 months ago - By: Zacks Investment Research - Mentions: GILD MRK

Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold?